Miaoyan Wei

804 total citations
24 papers, 524 citations indexed

About

Miaoyan Wei is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, Miaoyan Wei has authored 24 papers receiving a total of 524 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 10 papers in Molecular Biology and 7 papers in Surgery. Recurrent topics in Miaoyan Wei's work include Pancreatic and Hepatic Oncology Research (14 papers), Cancer-related molecular mechanisms research (5 papers) and Pancreatitis Pathology and Treatment (4 papers). Miaoyan Wei is often cited by papers focused on Pancreatic and Hepatic Oncology Research (14 papers), Cancer-related molecular mechanisms research (5 papers) and Pancreatitis Pathology and Treatment (4 papers). Miaoyan Wei collaborates with scholars based in China, Austria and India. Miaoyan Wei's co-authors include Xianjun Yu, Si Shi, Jie Hua, Jin Xu, Qingcai Meng, Yiyin Zhang, Jiang Liu, Chen Liang, Bo Zhang and Liang Chen and has published in prestigious journals such as International Journal of Molecular Sciences, Frontiers in Immunology and Molecular Cancer.

In The Last Decade

Miaoyan Wei

21 papers receiving 520 citations

Peers

Miaoyan Wei
Xiaopin Ji China
Zeyu Shuang China
Ertao Zhai China
Xiaojian Ni China
Guoyin Li China
Mengxuan Yang China
Satoe Fujiwara Japan
М. К. Ибрагимова Russia
Teruhide Ishigame Japan
Pina Ziranu Italy
Xiaopin Ji China
Miaoyan Wei
Citations per year, relative to Miaoyan Wei Miaoyan Wei (= 1×) peers Xiaopin Ji

Countries citing papers authored by Miaoyan Wei

Since Specialization
Citations

This map shows the geographic impact of Miaoyan Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miaoyan Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miaoyan Wei more than expected).

Fields of papers citing papers by Miaoyan Wei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miaoyan Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miaoyan Wei. The network helps show where Miaoyan Wei may publish in the future.

Co-authorship network of co-authors of Miaoyan Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Miaoyan Wei. A scholar is included among the top collaborators of Miaoyan Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miaoyan Wei. Miaoyan Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xiao, Mingming, Yangyi Li, Jintong Na, et al.. (2025). The Role of Senescence, its Therapeutic Relevance and Clinical Implications in the Tumor Microenvironment. Theranostics. 15(16). 8675–8703.
2.
Jiang, Chunjuan, Miaoyan Wei, Panli Li, et al.. (2025). A pilot study of nectin-4-targeted radioligand [68Ga]Ga-FZNR-1 in patients with pancreatic ductal adenocarcinoma: head-to-head comparison with [18F]-FDG. European Journal of Nuclear Medicine and Molecular Imaging. 53(4). 2362–2374.
3.
Ma, Zhilong, Jie Hua, Miaoyan Wei, et al.. (2025). The pancreatitis-cancer transformation-related factor, human rhomboid family-1, promotes pancreatic cancer progression through the SRC/YAP signaling pathway. Translational Oncology. 54. 102346–102346. 1 indexed citations
4.
5.
Hua, Jie, Miaoyan Wei, Qingcai Meng, et al.. (2023). A new approach: Evaluation of necroptosis and immune status enables prediction of the tumor microenvironment and treatment targets in pancreatic cancer. Computational and Structural Biotechnology Journal. 21. 2419–2433. 2 indexed citations
6.
7.
Hua, Jie, Jiang Liu, Miaoyan Wei, et al.. (2022). Pyroptosis-related lncRNA pairs to estimate the molecular features and prognostic outcomes of pancreatic ductal adenocarcinoma. Translational Oncology. 25. 101524–101524. 2 indexed citations
8.
Liu, Xiaomeng, Jiang Liu, Jin Xu, et al.. (2022). Intra-tumoral infiltration of adipocyte facilitates the activation of antitumor immune response in pancreatic ductal adenocarcinoma. Translational Oncology. 27. 101561–101561. 5 indexed citations
9.
Hua, Jie, Jin Xu, Miaoyan Wei, et al.. (2022). Turning towards nonimmunoreactive tumors: Evaluation of cancer-associated fibroblasts enables prediction of the immune microenvironment and treatment sensitivity in pancreatic cancer. Computational and Structural Biotechnology Journal. 20. 3911–3923. 3 indexed citations
10.
Hua, Jie, Miaoyan Wei, Liang Chen, et al.. (2022). Turning up the heat on non-immunoreactive tumors: autophagy influences the immune microenvironment in pancreatic cancer. BMC Medical Genomics. 15(1). 218–218. 1 indexed citations
11.
Hua, Jie, Jiang Liu, Miaoyan Wei, et al.. (2022). Comprehensive analysis of the prognosis and immune infiltration landscape of RNA methylation-related subtypes in pancreatic cancer. BMC Cancer. 22(1). 804–804. 7 indexed citations
12.
Lu, Siyuan, Jie Hua, Jin Xu, et al.. (2021). Microorganisms in chemotherapy for pancreatic cancer: An overview of current research and future directions. International Journal of Biological Sciences. 17(10). 2666–2682. 13 indexed citations
13.
Wei, Miaoyan, Jin Xu, Jie Hua, et al.. (2021). From the Immune Profile to the Immunoscore: Signatures for Improving Postsurgical Prognostic Prediction of Pancreatic Neuroendocrine Tumors. Frontiers in Immunology. 12. 654660–654660. 7 indexed citations
14.
Wei, Miaoyan, Bingxin Gu, Shaoli Song, et al.. (2021). A Novel Validated Recurrence Stratification System Based on 18F-FDG PET/CT Radiomics to Guide Surveillance After Resection of Pancreatic Cancer. Frontiers in Oncology. 11. 650266–650266. 7 indexed citations
15.
Meng, Qingcai, Chen Liang, Jie Hua, et al.. (2020). A miR-146a-5p/TRAF6/NF-kB p65 axis regulates pancreatic cancer chemoresistance: functional validation and clinical significance. Theranostics. 10(9). 3967–3979. 116 indexed citations
16.
17.
Zhang, Yiyin, Jin Xu, Jie Hua, et al.. (2019). A PD-L2-based immune marker signature helps to predict survival in resected pancreatic ductal adenocarcinoma. Journal for ImmunoTherapy of Cancer. 7(1). 233–233. 44 indexed citations
18.
Wei, Miaoyan, Pei‐Yi Lin, Zhisheng Chen, et al.. (2017). Integrated mRNA and lncRNA expression profiling for exploring metastatic biomarkers of human intrahepatic cholangiocarcinoma.. PubMed. 7(3). 688–699. 28 indexed citations
19.
Wei, Miaoyan, Lisheng Lü, Pei‐Yi Lin, et al.. (2016). Multiple cellular origins and molecular evolution of intrahepatic cholangiocarcinoma. Cancer Letters. 379(2). 253–261. 30 indexed citations
20.
Yi, Bin, Weidan Ji, Miaoyan Wei, et al.. (2016). Desulfation of cell surface HSPG is an effective strategy for the treatment of gallbladder carcinoma. Cancer Letters. 381(2). 349–358. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiaopin Ji Breakdown of academic impact, for papers by Zeyu Shuang Breakdown of academic impact, for papers by Ertao Zhai Breakdown of academic impact, for papers by Xiaojian Ni Breakdown of academic impact, for papers by Guoyin Li Breakdown of academic impact, for papers by Mengxuan Yang Breakdown of academic impact, for papers by Satoe Fujiwara Breakdown of academic impact, for papers by М. К. Ибрагимова Breakdown of academic impact, for papers by Teruhide Ishigame Breakdown of academic impact, for papers by Pina Ziranu
Rankless by CCL
2026